ABSTRACT
Breast cancer (BC) is a major concern globally, and significant research is being carried out to find a better treatment. This includes the discovery of new drugs, testing new drug combinations, and drug repurposing, among other related interventions. One such example is provided by metronomic chemotherapy. The results of multiple studies have established metronomic chemotherapy as a novel therapeutic approach to prevent many different types of cancers, including BC. The field of nanotechnology has shown excellent advancements in the medical field, especially in the drug delivery process. With the smaller particle size of nanometers, specific site targeting could be achieved for the treatment of cancer by using nanomedicines, increasing their bioavailability, and planning minimally damaging side effects. Additionally, using a small number of medications results in cost reductions. This chapter highlights the advances made in the field of MCT in terms of nanotechnology, and a special focus has been applied in terms of its advantages as compared to traditional chemotherapy.
